Correction to “Development of nanoparticle‐based drug delivery system for inflammation treatment and diagnosis”. // MedComm - Biomaterials and Applications. – 2026. – DOI: 10.1002/mba2.70101. – URL: https://onlinelibrary.wiley.com/doi/10.1002/mba2.70101?af=R
(2026). Correction to “Development of nanoparticle‐based drug delivery system for inflammation treatment and diagnosis”. MedComm - Biomaterials and Applications. https://doi.org/10.1002/mba2.70101
“Correction to “Development of nanoparticle‐based drug delivery system for inflammation treatment and diagnosis”.” MedComm - Biomaterials and Applications, 2026. doi:10.1002/mba2.70101.
@article{article84417,
title = {Correction to “Development of nanoparticle‐based drug delivery system for inflammation treatment and diagnosis”},
journal = {MedComm - Biomaterials and Applications},
year = {2026},
doi = {10.1002/mba2.70101},
url = {https://onlinelibrary.wiley.com/doi/10.1002/mba2.70101?af=R}
}
Nature Biomedical Engineering, Published online: 18 November 2026; doi:10.1038/s41551-026-01843-z Tumour-associated mucins induce the disassembly of a designer PEGylated paclitaxel-conjugated nanomedicine into small unimers that escape...